BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27133126)

  • 1. Optimization of a method for preparing solid complexes of essential clove oil with β-cyclodextrins.
    Hernández-Sánchez P; López-Miranda S; Guardiola L; Serrano-Martínez A; Gabaldón JA; Nuñez-Delicado E
    J Sci Food Agric; 2017 Jan; 97(2):420-426. PubMed ID: 27133126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical characterization and antibacterial activity of inclusion complexes of Hyptis martiusii Benth essential oil in β-cyclodextrin.
    Andrade TA; Freitas TS; Araújo FO; Menezes PP; Dória GAA; Rabelo AS; Quintans-Júnior LJ; Santos MRV; Bezerra DP; Serafini MR; Menezes IRA; Nunes PS; Araújo AAS; Costa MS; Campina FF; Santos ATL; Silva ARP; Coutinho HDM
    Biomed Pharmacother; 2017 May; 89():201-207. PubMed ID: 28226293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
    Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
    Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clove essential oil-in-cyclodextrin-in-liposomes in the aqueous and lyophilized states: From laboratory to large scale using a membrane contactor.
    Sebaaly C; Charcosset C; Stainmesse S; Fessi H; Greige-Gerges H
    Carbohydr Polym; 2016 Mar; 138():75-85. PubMed ID: 26794740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins.
    Ain S; Philip B; Pathak K
    PDA J Pharm Sci Technol; 2008; 62(4):300-8. PubMed ID: 19174958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.
    Ali AA; Sayed OM
    Pharm Dev Technol; 2013; 18(5):1042-50. PubMed ID: 22206481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexation of estragole as pure compound and as main component of basil and tarragon essential oils with cyclodextrins.
    Kfoury M; Auezova L; Ruellan S; Greige-Gerges H; Fourmentin S
    Carbohydr Polym; 2015 Mar; 118():156-64. PubMed ID: 25542121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
    Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
    Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, Characterization, and Properties of Inclusion Complexes of Balofloxacin with Cyclodextrins.
    Ren X; Qian H; Tang P; Tang Y; Liu Y; Pu H; Zhang M; Zhao L; Li H
    AAPS PharmSciTech; 2019 Aug; 20(7):278. PubMed ID: 31396732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
    Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
    J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion phenomena of clove oil with alpha-, beta-, gamma- and heptakis (2,6-di-O-methyl)-beta-cyclodextrin.
    Song LX; Xu P; Wang HM; Yang Y
    Nat Prod Res; 2009; 23(9):789-800. PubMed ID: 19306153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.